These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32860467)

  • 1. Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients.
    Pawlowska AB; Karras NA; Liu H; DiMundo J; Cheng JC; Sun W; Armenian S; Yang D; Palmer JM; Bell A; Tahoun A; Tegtmeier B; Dadwal S; Rosenthal J
    Transpl Infect Dis; 2021 Feb; 23(1):e13453. PubMed ID: 32860467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease.
    Han TT; Zhang YN; Sun YQ; Kong J; Wang FR; Wang ZD; Cheng YF; Yan CH; Wang Y; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
    Transpl Infect Dis; 2021 Jun; 23(3):e13544. PubMed ID: 33326670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
    Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality.
    Winestone LE; Punn R; Tamaresis JS; Buckingham J; Pinsky BA; Waggoner JJ; Kharbanda S
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29181879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
    Chan PK; Li CK; Chik KW; Lee V; Shing MM; Ng KC; Cheung JL; Fok TF; Cheng AF
    J Med Virol; 2004 Apr; 72(4):668-74. PubMed ID: 14981771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.
    El Jurdi N; Rogosheske J; DeFor T; Bejanyan N; Arora M; Bachanova V; Betts B; He F; Holtan S; Janakiram M; Larson S; Maakaron J; Rashidi A; Warlick E; Wagner JE; Young JH; Weisdorf D; Brunstein CG
    Transplant Cell Ther; 2021 Jan; 27(1):84.e1-84.e5. PubMed ID: 33053448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.
    Zerr DM; Boeckh M; Delaney C; Martin PJ; Xie H; Adler AL; Huang ML; Corey L; Leisenring WM
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1700-8. PubMed ID: 22641196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
    Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
    Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease.
    Verhoeven DH; Claas EC; Jol-van der Zijde CM; Thijssen JC; Lankester AC; Bredius RG; Putter H; Kroes AC; Egeler RM; Schilham MW; van Tol MJ
    Pediatr Infect Dis J; 2015 Oct; 34(10):1118-27. PubMed ID: 26132825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT.
    Hill JA; Nichols WG; Marty FM; Papanicolaou GA; Brundage TM; Lanier R; Zerr DM; Boeckh MJ
    Blood; 2020 Apr; 135(17):1447-1451. PubMed ID: 32076716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognosis of human herpesvirus 6 reactivation following allogeneic hematopoietic stem cell transplantation.
    Iesato K; Hori T; Yoto Y; Yamamoto M; Inazawa N; Kamo K; Ikeda H; Iyama S; Hatakeyama N; Iguchi A; Sugita J; Kobayashi R; Suzuki N; Tsutsumi H
    Pediatr Int; 2018 Jun; 60(6):547-552. PubMed ID: 29542206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
    Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation.
    Tamaki H; Ikegame K; Yoshihara S; Kaida K; Yoshihara K; Inoue T; Kato R; Nakata J; Fujioka T; Soma T; Okada M; Ogawa H
    Transpl Infect Dis; 2019 Jun; 21(3):e13073. PubMed ID: 30875143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.
    Olson AL; Dahi PB; Zheng J; Devlin SM; Lubin M; Gonzales AM; Giralt SA; Perales MA; Papadopoulos EB; Ponce DM; Young JW; Kernan NA; Scaradavou A; O'Reilly RJ; Small TN; Papanicolaou G; Barker JN
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):787-93. PubMed ID: 24548875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
    Lagadinou ED; Marangos M; Liga M; Panos G; Tzouvara E; Dimitroulia E; Tiniakou M; Tsakris A; Zoumbos N; Spyridonidis A
    Transpl Infect Dis; 2010 Oct; 12(5):437-40. PubMed ID: 20561301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.
    Miyashita N; Endo T; Onozawa M; Hashimoto D; Kondo T; Fujimoto K; Kahata K; Sugita J; Goto H; Matsukawa T; Hashino S; Teshima T
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt.
    Raouf MME; Ouf NM; Elsorady MAS; Ghoneim FM
    Virol J; 2023 Feb; 20(1):20. PubMed ID: 36739398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation.
    Vittayawacharin P; E'Leimat G; Lee BJ; Griffin S; Doh J; Nam H; Blodget E; Jeyakumar D; Kongtim P; Ciurea SO
    Transplant Cell Ther; 2023 Jun; 29(6):397.e1-397.e6. PubMed ID: 36878429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Herpesvirus-6B Reactivation Is a Risk Factor for Grades II to IV Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Phan TL; Carlin K; Ljungman P; Politikos I; Boussiotis V; Boeckh M; Shaffer ML; Zerr DM
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2324-2336. PubMed ID: 29684567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.